Life Science Alliance | Patient-specific analysis of co-expression to measure biological network rewiring in individuals

Issuing time:2025-10-29 14:44Author:Lanying Wei, Yucui Xin,Mengchen Pu,Yingsheng ZhangLink:https://doi.org/10.26508/lsa.202302253

To effectively understand the underlying mechanisms of disease and inform the development of personalized therapies, it is critical to harness the power of differential co-expression (DCE) network analysis. Despite the promise of DCE network analysis in precision medicine, current approaches have a major limitation: they measure an average differential network across multiple samples, which means the specific etiology of individual patients is often overlooked. To address this, we present Cosinet, a DCE-based single-sample network rewiring degree quantification tool. By analyzing two breast cancer datasets, we demonstrate that Cosinet can identify important differences in gene co-expression patterns between individual patients and generate scores for each individual that are significantly associated with overall survival, recurrence-free interval, and other clinical outcomes, even after adjusting for risk factors such as age, tumor size, HER2 status, and PAM50 subtypes. Cosinet represents a remarkable development toward unlocking the potential of DCE analysis in the context of precision medicine.


Follow Us
Address: 7 temasek boulevard,#12-07 suntec tower 1, singapore 038987
BD Inquiries: bd@imolx.com
Technical Support: support@imolx.com
Media Inquiries: press@imolx.com
General Inquiries: info@imolx.com